TY - JOUR
T1 - The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk
AU - Nannya, Yasuhito
AU - Kataoka, Keisuke
AU - Hangaishi, Akira
AU - Imai, Yoichi
AU - Takahashi, Tsuyoshi
AU - Kurokawa, Mineo
PY - 2011/5
Y1 - 2011/5
N2 - Optimal donor selection is one of the key factors to enhance the success rate of allogeneic hematopoietic stem cell transplantation (HSCT). The effect of sex mismatch, especially the effect of Y chromosome mismatch in graft-versus-host disease (GVHD) direction (female donors to male recipients: denoted as FtoM mismatch) on overall survival (OS) has been controversial and not examined out of the patient population in Western countries. We retrospectively analyzed 225 cases of allogeneic HSCT and showed that FtoM mismatch confers a highly significant impact on OS (P < 0.005) in Japanese population. We demonstrated that this effect depends on the disease risk; for standard risk cases, this effect was significantly associated with poor outcome (for OS, P = 0.021), while for high risk cases, it had no effect on the results (for OS, P = 0.26). We further showed that FtoM mismatch was associated with nonrelapse mortality (P = 0.019) and most of them were GVHD-related in standard risk cases. In conclusion, FtoM mismatch has a significant impact on transplant outcome, especially in standard risk cases.
AB - Optimal donor selection is one of the key factors to enhance the success rate of allogeneic hematopoietic stem cell transplantation (HSCT). The effect of sex mismatch, especially the effect of Y chromosome mismatch in graft-versus-host disease (GVHD) direction (female donors to male recipients: denoted as FtoM mismatch) on overall survival (OS) has been controversial and not examined out of the patient population in Western countries. We retrospectively analyzed 225 cases of allogeneic HSCT and showed that FtoM mismatch confers a highly significant impact on OS (P < 0.005) in Japanese population. We demonstrated that this effect depends on the disease risk; for standard risk cases, this effect was significantly associated with poor outcome (for OS, P = 0.021), while for high risk cases, it had no effect on the results (for OS, P = 0.26). We further showed that FtoM mismatch was associated with nonrelapse mortality (P = 0.019) and most of them were GVHD-related in standard risk cases. In conclusion, FtoM mismatch has a significant impact on transplant outcome, especially in standard risk cases.
KW - Disease risk
KW - Hematopoietic stem cell transplantation
KW - Sex mismatch
UR - http://www.scopus.com/inward/record.url?scp=79953772864&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953772864&partnerID=8YFLogxK
U2 - 10.1111/j.1432-2277.2011.01229.x
DO - 10.1111/j.1432-2277.2011.01229.x
M3 - Article
C2 - 21294789
AN - SCOPUS:79953772864
SN - 0934-0874
VL - 24
SP - 469
EP - 476
JO - Transplant International
JF - Transplant International
IS - 5
ER -